|
|
Volumn 30, Issue 3, 2012, Pages 198-
|
|
Another nail in the biosimilar coffin?
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
US FOOD AND DRUG ADMINISTRATION;
BIOTECHNOLOGY;
ERYTHROPOIETIN;
RECOMBINANT ERYTHROPOIETIN;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG SUBSTITUTION;
EUROPEAN UNION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PATIENT SELECTION;
PHARMACIST;
PRIORITY JOURNAL;
REVIEW;
TREATMENT RESPONSE;
UNITED STATES;
BIOLOGICAL AGENTS;
GOVERNMENT REGULATION;
GUIDELINES AS TOPIC;
LEGISLATION, DRUG;
REFERENCE VALUES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84857944898
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2169 Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|